Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis-Reference-Cited by-同舟云学术

Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis

Published:2019-11-12 Issue:3 Volume:267 Page:674-678
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Gomez-Figueroa Enrique^ORCID,Garcia-Trejo Sofía,Bazan-Rodriguez Lisette,Cervantes-Uribe Roberto,Chac-Lezama German,López-Hernández Juan Carlos,Vargas-Cañas Steven

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-019-09622-4.pdf

Reference19 articles.

1. Sieb JP (2014) Myasthenia gravis: an update for the clinician. Clin Exp Immunol. https://doi.org/10.1111/cei.12217

2. Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. https://doi.org/10.1038/nri916

3. Ha JC, Richman DP (2015) Myasthenia gravis and related disorders: Pathology and molecular pathogenesis. Biochim Biophys Acta-Mol Basis Dis. https://doi.org/10.1016/j.bbadis.2014.11.022

4. Keesey JC (2004) Clinical evaluation and management of myasthenia gravis. Muscle Nerve. https://doi.org/10.1002/mus.20030

5. Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. https://doi.org/10.1016/S1474-4422(15)00145-3

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction cyclophosphamide with maintenance immunosuppression in high-risk myasthenia gravis: long-term follow-up and safety profile;Journal of Neurology, Neurosurgery & Psychiatry;2024-07-04

2. Immune mediated myasthenia gravis in children, current concepts and new treatments: A narrative review article;IRAN J CHILD NEUROL;2024

3. Advances in Immunotherapy for Myasthenia Gravis;Advances in Clinical Medicine;2024

4. Myasthenia Gravis: A Systematic Review;Cureus;2023-12-06

5. Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report;Journal of Neurology;2023-10-07